A ARGX

Argen X SE

BIOTECHNOLOGY · HEALTHCARE

argenx NV, based in Breda, the Netherlands, is a forward-thinking clinical-stage biotechnology company focused on delivering transformative antibody-based treatments for severe autoimmune diseases, hematological disorders, and various cancers. Leveraging its proprietary technology platform, argenx i...

$844.41

-0.34% ($2.85)

Volume 245,319

52W High $934.62

52W Low $510.06

Market Cap $52.25B

← Back to Calendar Compare with Others →

What to Watch This Quarter

Based on historical data

Consensus EPS

$5.26

Whisper EPS

$6.05

15.0% above consensus

Last Quarter

$5.18

Current Streak

3 Beats

Avg Surprise (4Q)

+99.57%

Next Earnings Report

Reports in 1 day

Report Date Feb 26, 2026

Time BMO

Whisper Spread +15.00%

Consensus Estimate

$5.26

Official analyst average

Whisper Number

$6.05

What traders expect

Bullish Sentiment: The whisper number is 15.0% above consensus, suggesting traders expect a strong beat. The stock may be priced for upside surprise.

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q3 2025 Oct 30, 2025

1-Day: -0.23%

5-Day: +1.36%

Q2 2025 Jul 15, 2025

1-Day: +3.95%

Q1 2025 May 7, 2025

1-Day: -8.64%

5-Day: -9.96%

Q4 2024 Feb 27, 2025

1-Day: 0.00%

5-Day: -0.55%

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q3 2025	Oct 30, 2025	$4.44	$5.11	$5.18	+16.67%	Beat
Q2 2025	Jul 15, 2025	-$0.99	-$0.99	$3.26	--	Beat
Q1 2025	May 7, 2025	$2.05	$2.36	$2.27	+10.64%	Missed
Q4 2024	Feb 27, 2025	$1.70	$1.95	$0.71	-58.04%	Missed
Q3 2024	Oct 31, 2024	$0.03	$0.03	$1.39	--	Beat
Q2 2024	Jul 25, 2024	-$0.98	-$0.98	$0.45	--	Beat
Q1 2024	May 9, 2024	-$0.86	-$0.86	-$1.04	-20.93%	Missed
Q4 2023	Feb 29, 2024	-$1.70	-$1.70	-$1.68	+1.18%	Beat
Q3 2023	Oct 31, 2023	-$1.54	-$1.54	-$1.25	+18.83%	Beat
Q2 2023	Jul 27, 2023	-$1.73	-$1.73	-$1.69	+2.31%	Beat
Q1 2023	May 7, 2023	-$2.26	-$2.26	-$0.71	+68.58%	Beat
Q4 2022	Mar 2, 2023	-$0.70	-$0.70	-$0.70	+0.00%	Met